eMedevents

EMCREG-International Newsletter: Management of Life-threatening Bleeding in the Anticoagulated Patient is organized by University of Cincinnati Continuing Medical Education (UC-CME) and will be held from Aug 01, 2019 - Jul 31, 2020. This Conference has been approved for a maximum of 1 AMA PRA Category 1 Credit™.

Target Audience:
Cardiology, Emergency Medicine, Hospitalists, Nurse Practitioners, Physician Assistant, Physicians, Trauma/Critical Care

Description:
EMCREG-International Newsletter: Management of Life-threatening Bleeding in the Anticoagulated Patient

Objectives:
As a result of participating in the enduring material activity, participants should be able to:
• Describe the results and significance of the ANNEXA-4 clinical trial of andexanet alfa in patients with severe bleeding due to Factor Xa inhibitors.
• Summarize the specific approaches to emergency management of bleeding related to oral anticoagulant therapy.
• Describe how this approach varies according to the particular oral anticoagulant, the urgency of the need for reversal, and the medical setting.
• Describe the mechanism of action of the anticoagulant reversal agents, idarucizumab and andexanet alfa.
• List the specific indications for the use of vitamin K, fresh frozen plasma, prothrombin complex concentrate, idarucizumab, and andexanet alfa in a patient with severe oral anticoagulant associated bleeding.

Additional details will be posted as soon as information is available.

Intended Audience

Emergency Medicine, Hematology Blood and Marrow Transplant

Activity Payment Details

Activity Fee : Free

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

University of Cincinnati Continuing Medical Education (UC-CME)

View Organizer Details

Help

513-558-7277